⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
AZN
LLY
NVO
PFE
AMGN
BMY
JNJ
REGN
VKTX
ZETA
CRSP
IONS
AXSM
MRK
GSK
SNY
IMUX
BMEA
ALKS
ALT
AARD
NOV
CARM
CRIS
LPCN
GILD
REG
SPRO
ABSI
ALZN
ANVS
BV
ARCL
ACIU
Transforming Bioprocessing for the Digital Age Takes Center Stage at the Bioprocessing Summit 2026
prnewswire.com
GILD
GSK
PFE
Secretome Therapeutics Expands Rare Disease Leadership Team
businesswire.com
SRPT
RPRX
PFE
BIIB
GILD
AMGN
ATRA
Former Pfizer HQ Evacuation Puts Office Conversions Under Structural Scrutiny
prnewswire.com
PFE
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
prnewswire.com
BMY
AZN
PFE
Simmons Hanly Conroy Named Partner Jayne Conroy Honored with 2026 "David Egilman Make the World a Better Place Award"
accessnewswire.com
PFE
META
GOOGL
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
businesswire.com
PFE
Cheiron Raises $8M Seed Led by Menlo Ventures to Build the Operating System for Drug Programs
globenewswire.com
MRNA
PFE